Clinical Trial Update: PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase pilot studies evaluated PSMA-targeted PET imaging with 18F-DCFPyL (Pylarify) in prostate cancer using PET/CT and PET/MRI; the trial status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer
• Prostate Neoplasm

Drugs mentioned

• Pylarify (piflufolastat F-18)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Prostate Cancer, Prostate Neoplasm | EARLY_Phase 1 | Status: COMPLETED